Neoadjuvant Nivolumab in Glioblastoma

NCT02550249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Nivolumab

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra